Skip to main content
OpenTrials

Clinical trial condition

Epstein-Barr Virus Infections

Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.

695 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Epstein-Barr Virus Infections trial results

Recruiting

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

NCT06137118

Conditions
B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site Tampa, Florida, United States
View all 82 locations
View Trial Details
Recruiting

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

NCT05082519

Conditions
B-cell Acute Lymphoblastic Leukemia, Body Weight, Burkitt Lymphoma, +29 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • Colorado Children's Hospital Denver, Colorado, United States
View all 16 locations
View Trial Details
Recruiting

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

NCT07223021

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Cincinnati Children's Hospital Medical Center (Data Collection Only) Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia (Data Collection Only) Philadelphia, Pennsylvania, United States
  • Baylor College Medical Center (Data Collection Only) Houston, Texas, United States
View Trial Details
Recruiting

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

NCT06927466

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations
  • Peking University People's Hospital Beijing, China
  • Jiangxi Province pediatric hospital Nanchang, China
  • The First Affiliated Hospital of Nanchang University Nanchang, China
  • Children's Hospital of Shanghai Shanghai, China
View Trial Details
Recruiting

A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

NCT07570173

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Rigshospitalet ( Site 0802) Copenhagen, Capital Region, Denmark
  • Aarhus Universitetshospital. Hæmatologisk afdeling ( Site 0804) Aarhus Nord, Central Jutland, Denmark
  • Odense Universitetshospital ( Site 0801) Odense, Region Syddanmark, Denmark
  • Rambam Health Care Campus ( Site 0903) Haifa, Israel
View all 18 locations
View Trial Details
Recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

NCT06287229

Conditions
B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions